期刊文献+

Association of defective HLA-Ⅰ expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer 被引量:12

Association of defective HLA-Ⅰ expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer
原文传递
导出
摘要 Background It has been confirmed that defective expression of human leukocyte antigen class Ⅰ (HLA-Ⅰ) molecules can contribute to the immune evasion of cancer cells in some types of cancer. The aim of this study was to examine the expression of HLA class Ⅰ antigen and the antigen-processing machinery (APM) components in esophageal squamous cell carcinoma (ESCC) and their role in high risk human papillomavirus (HPV) infection, and to analyze their association with histopathological characteristics in the Kazak ethnic group.Methods A total of 50 formalin-fixed, paraffin-embedded ESCC lesions were collected from the First Affiliated Hospital of Xinjiang Medical University, China. The expression levels of HLA-Ⅰ antigen and APM components were determined by immunohistochemistry; the HPV DNA were detected using polymerase chain reaction (PCR).Results A high frequency of down-regulation or loss of expression of HLA and APM components were found in esophageal cancer in Kazak people. HLA-Ⅰ, TAP1, CNX, LMP7, Erp57, Tapasin and ERAP1 were down-regulated in 68%,44%, 48%, 40%, 52%, 32% and 20% of ESCC lesions then, respectively. The loss of expression of HLA-Ⅰ antigen was significantly correlated with part of the APM components and positively correlated with high risk HPV16 infection. TAP1,CNX, LMP7, Erp57 and Tapasin loss were significantly associated with tumor grading, lymph node metastasis and depth of invasion (P〈0.05).Conclusion Our results suggest that APM component defects are a mechanism underlying HLA-Ⅰ antigen down-regulation in ESCC lesions, and indicate that the loss expression of HLA-Ⅰ and APM components will become an important marker of ESCC and analysis of HLA-Ⅰ and APM component expression can provide useful prognostic information for patients with ESCC from the Kazak ethnic group. Background It has been confirmed that defective expression of human leukocyte antigen class Ⅰ (HLA-Ⅰ) molecules can contribute to the immune evasion of cancer cells in some types of cancer. The aim of this study was to examine the expression of HLA class Ⅰ antigen and the antigen-processing machinery (APM) components in esophageal squamous cell carcinoma (ESCC) and their role in high risk human papillomavirus (HPV) infection, and to analyze their association with histopathological characteristics in the Kazak ethnic group.Methods A total of 50 formalin-fixed, paraffin-embedded ESCC lesions were collected from the First Affiliated Hospital of Xinjiang Medical University, China. The expression levels of HLA-Ⅰ antigen and APM components were determined by immunohistochemistry; the HPV DNA were detected using polymerase chain reaction (PCR).Results A high frequency of down-regulation or loss of expression of HLA and APM components were found in esophageal cancer in Kazak people. HLA-Ⅰ, TAP1, CNX, LMP7, Erp57, Tapasin and ERAP1 were down-regulated in 68%,44%, 48%, 40%, 52%, 32% and 20% of ESCC lesions then, respectively. The loss of expression of HLA-Ⅰ antigen was significantly correlated with part of the APM components and positively correlated with high risk HPV16 infection. TAP1,CNX, LMP7, Erp57 and Tapasin loss were significantly associated with tumor grading, lymph node metastasis and depth of invasion (P〈0.05).Conclusion Our results suggest that APM component defects are a mechanism underlying HLA-Ⅰ antigen down-regulation in ESCC lesions, and indicate that the loss expression of HLA-Ⅰ and APM components will become an important marker of ESCC and analysis of HLA-Ⅰ and APM component expression can provide useful prognostic information for patients with ESCC from the Kazak ethnic group.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第3期341-346,共6页 中华医学杂志(英文版)
基金 This study was supported by the grants from the National Natural Science Foundation of China (No. 81060164) and the Xinjiang Uygur Autonomous Region Fund(No.2009211B14).
关键词 antigen processing machinery human leukocyte antigen class Kazak's esophageal cancer human papillomavirus antigen processing machinery human leukocyte antigen class Ⅰ Kazak's esophageal cancer human papillomavirus
  • 相关文献

参考文献22

  • 1Tytgat GN,Bartelink H,Bernards R,Giaccone G,van Lanschot JJ,Offerhaus GJ,et al.Cancer of the esophagus and gastric cardia:recent advances.Dis Esophagus 2004; 17:10-26. 被引量:1
  • 2Zhang Y.The distribution of esophageal cancer in Xinjiang.J Xinjiang Med Univ(Chin) 1988;11:139-144. 被引量:1
  • 3Lu XM,Monnier-Benoit S,Mo LZ,Xu SY,Prétet JL,Liu Z,et al.Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang,China.Eur J Surg Oncol 2008; 34:765-770. 被引量:1
  • 4de Boer M,Jordanova E,van Poelgeest M,van den Akker B,van der Burg S,Kenter G,et al.Circulating human papillomavirus type 16 specific T-cells are associated with HLA class Ⅰ expression on tumor cells,but not related to the amount of viral oncogene transcripts.Int J Cancer 2007; 121:2711-2715. 被引量:1
  • 5Breitburd F,Ramoz N,Salmon J,Orth G.HLA control in the progression of human papillomavirus infections.Semin Cancer Biol 1996; 7:359-371. 被引量:1
  • 6Natarajan K,Li H,Mariuzza R,Margulies D.MHC class Ⅰ molecules,structure and function.Rev Immunogenet 1999; 1:32-46. 被引量:1
  • 7Paulsson K.Evolutionary and functional perspectives of the major histocompatibility complex class Ⅰ antigen-processing machinery.Cell Mol Life Sci 2004; 61:2446-2460. 被引量:1
  • 8Zhang Y,Williams DB.Assembly of MHC class Ⅰ molecules within the endoplasmic reticulum.Immunol Res 2006; 34(1-2):151-162. 被引量:1
  • 9Seliger B,Ritz U,Ferrone S.Molecular mechanisms of HLA class Ⅰ antigen abnormalities following viral infection and transformation.Int J Cancer 2006; 118:129-138. 被引量:1
  • 10Gromme M,Neefjes J.Antigen degradation or presentation by MHC class Ⅰ molecules via classical and non-classical pathways.Mol Immunol 2002;39:181-202. 被引量:1

同被引文献63

引证文献12

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部